Sichuan Cancer hospital. ( Site 2218) — Chengdu, Sichuan

Public research footprint of Sichuan Cancer hospital. ( Site 2218), compiled from the ClinicalTrials.gov public registry.

324

Registered studies

211

Active

124

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer (NSCLC) · Carcinoma, Non-Small-Cell Lung · Solid Tumors

Recently updated registry entries

NCT07554339 — A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… (Recruiting)
NCT07227597 — A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People… (Recruiting)
NCT06997497 — A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sichuan Cancer hospital. ( Site 2218)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.